Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection

Rheumatology International

Volumn 30, Issue 5, 2010, Pages 679-680

  Schafranski, Marcelo Derbli ^a,b  

^a Bom Jesus Hospital   (Brazil)

^b Centro CEP   (Brazil)

Author keywords

Chlamydia; Infliximab; Reactive arthritis; TNF alpha

Indexed keywords

DOXYCYCLINE; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTHRALGIA; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; CHLAMYDIASIS; CLINICAL FEATURE; DISEASE CONTROL; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; HUMAN; JOINT SWELLING; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; PREDNISONE; SULFASALAZINE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951025518     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0965-9     Document Type: Article

References (8)

1. Carter JD (2006) Reactive arthritis: deWned etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin North Am 20(4):827-847. doi:10.1016/j.idc.2006.09.004 (Pubitemid 44762256)
2. Reveille JD, Arnett FC (2005) Spondyloarthritis: update on pathogenesis and management. Am J Med 118(6):592-603. doi:10.1016/ j.amjmed.2005.01.001
3. Furst DE, Breedveld FC, Kalden JR et al (2007) Updated consensus statement on biological agents for the treatment of rheumatic diseases. Ann Rheum Dis 66(suppl 3):2-22
4. Rihl M, Klos A, Köhler L, Kuipers JG (2006) Infection and musculoskeletal conditions: reactive arthritis. Best Pract Res Clin Rheumatol 20(6):1119-1137. doi:10.1016/j.berh.2006.08.008 (Pubitemid 44774815)
5. Butrimiene I, Jarmalaite S, Ranceva J, Venalis A, Jasiuleviciute L, Zvirbliene (2004) A DiVerent cytokine proWles in patients with chronic and acute reactive arthritis. Rheumatology (Oxford) 43(10):1300-1304. doi:10.1093/rheumatology/keh323 (Pubitemid 39359308)
6. Oili KS, Niinisalo H, Korpilähde T, Virolainen J (2003) Treatment of reactive arthritis with inXiximab. Scand J Rheumatol 32(2):122-124. doi:10.1080/03009740310000157 (Pubitemid 36428352)
7. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inXammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507-511
8. Gill H, Majithia V (2007) Successful use of inXiximab in the treatment of Reiter's syndrome: a case report and discussion. Clin Rheumatol 27(1):121-123. doi:10.1007/s10067-007-0692-0